| 1Atenolol |
|---|
| 2Impurity B |
| 3Impurity F |
| 4Impurity G |
| 5Impurity I |
| 6Impurity J |
Compound Name Atenolol |
CID 2249 |
Molecular Formula C14H22N2O3 |
Molecular Weight 266 |
No. Chiral Centers: 1 |
No. Hydrogen Bond Acceptors 4 |
No. Hydrogen Bond Donors 3 |
Applications
USP 621: Allowable changes Column Diameter-4.6mm ID
19228
Separation Mode: Reversed Phase
Reversed Phase
C18(2)
HPLC
Antihypertensive Agents
Pharmaceutical: Therapeutic Uses
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 19228)
Column: | ||||||
Brand Name: | ||||||
Part No: | ||||||
Phase Name: C18(2) | ||||||
Elution Type: Isocratic | ||||||
Mobile Phase: A: See analyst note | ||||||
Gradient Profile:
| ||||||
Flow Rate: 0.8 mL/min | ||||||
Temperature: 22°C | ||||||
Detection: UV-Vis Abs.-Variable Wave.(UV) (22°C) | ||||||
Sample Note: Isocratic: 100% of 2.0g of Sodium Octanesulphonate + 0.8g of Tetrabutyl Ammonium Hydrogen Sulphate in 2L of 360ml Methanol + 40ml of THF+1600ml of 3.4g of potassium Dihydrogen Phosphate in 2L of water (pH adjusted to 3.0 using Phosphoric acid) |
Order Items Used in This Application
00F-4252-E0
Luna 5 µm C18(2) 100 Å, LC Column 150 x 4.6 mm, Ea
Qty:
Similar Applications
search
Atenolol
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
